Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at Barclays PLC from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]Yahoo! Finance
- GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San FranciscoPR Newswire
- Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline [Yahoo! Finance]Yahoo! Finance
- Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]Seeking Alpha
LEGN
Sec Filings
- 1/23/26 - Form 6-K
- 1/21/26 - Form 6-K
- 1/14/26 - Form 6-K
- LEGN's page on the SEC website